Akanda Announces $12.0 Million Convertible Note Offering
Toronto, Ontario--(Newsfile Corp. - September 12, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced the execution and closing of a securities purchase agreement with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of up to $12.0 million, in a private placement transaction. The Company shall use the proceeds from the sale of the notes for (i) marketing purposes of up to $3
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-09-12 4:43 PM EDT | Akanda Corp
C21 Investments Announces Completion of Non-Dilutive Creation and Issuance of Subordinate Voting Shares
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced the completion of a transaction (the "Transaction") pursuant to which the Company has amended its authorized share structure and Articles to create a new class of subordinate voting shares ("Subordinate Voting Shares") and issued 100,000,000 of such newly created Subor
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2025-09-08 7:00 AM EDT | C21 Investments Inc.
C21 Investments Announces Settlement of Eco Firma Farms Litigation
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it has entered into a settlement agreement (the "Settlement Agreement") with respect to certain actions filed in the Oregon State Circuit Court for Clackamas County and the Oregon Court of Appeals by two owners (each, a "Vendor") of Proudest Monkey Holdin
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2025-09-04 10:59 PM EDT | C21 Investments Inc.
Akanda Corp. Announces Closing of Share Exchange with First Towers and Fiber Corp.
Toronto, Ontario--(Newsfile Corp. - August 22, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announc
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-08-22 4:15 PM EDT | Akanda Corp
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - August 22, 2025) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-3.125 reverse stock split of the Company's common shares effective August 26, 2025. The reverse stock split was previously approved by the Company's shareholders on April 30, 2025 and Board of Directors on August 8, 2025 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market o
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-08-22 8:00 AM EDT | Akanda Corp
Steep Hill Announces Appointment of Director
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that Ms. Sonia Agustina has been appointed as a Director of the Company, effective August 13, 2025. Ms. Agustina is a Chartered Professional Accountant with over 20 years of financial leadership experience in both public practice and industry, specializing in regulated, high-growth, and publicly listed companies. She currently serves
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-08-20 5:00 PM EDT | Steep Hill Inc.
Flora Regains Compliance with NASDAQ Minimum Bid Requirement
Fort Lauderdale, Florida--(Newsfile Corp. - August 20, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce that on August 19, 2025, it has received notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). Flora is now in compliance with all applicable listing standa
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-08-20 8:31 AM EDT | Flora Growth Corp.
Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin
Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona. Revenue of $13.4 million, up 59% YoY and a sequential increase of $1.8 million, reflecting first full quarter of consolidation of Big Perm dispensaries. Adjusted EBITDA[1] of $4.1 million, up $3 million from Q2 2024 and $0.7 million seque
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-08-20 6:30 AM EDT | VEXT Science, Inc.
Vext to Announce Financial Results for Q2 2025 on August 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before market open on August 20, 2025. The Company will host a conference call
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-08-11 7:30 AM EDT | VEXT Science, Inc.
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference
Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will participate in a Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference in Boston, MA, on August 12, 2025, at 9:30 a.m. EDT. A live webcast o
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-08-11 7:27 AM EDT | Cardiol Therapeutics Inc.
Delivra's Dream Water(R) Brand Expands Global Footprint with Launch of 6-Count Sleep Gummies into the Gulf Cooperation Council (GCC) Market
Vancouver, British Columbia--(Newsfile Corp. - August 7, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company in the health and wellness sector, is pleased to announce the upcoming launch of its new convenient 6-Count Sleep Gummies in key Middle Eastern markets in collaboration with its distribution partner in Saudi Arabia. This expansion will focus on the Gulf Cooperation Council (GCC) region, a high-gr
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-08-07 5:15 PM EDT | Delivra Health Brands Inc.
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring CardiolRx™ over placebo. Reduction in ECV was associated with improvements across multiple pre-specified cardiac magnetic resonance imaging (CMR) endpoints, including a significant reduction in LV mass. The ARCHER trial results provide compelling clinical proof of conce
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-08-06 7:27 AM EDT | Cardiol Therapeutics Inc.
Flora Growth Corp. Announces 1-for-39 Share Consolidation
Fort Lauderdale, Florida--(Newsfile Corp. - July 31, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company"), today announced that it will effect a 1-for-39 share consolidation of the Company's issued and outstanding common shares (the "Share Consolidation"). The Share Consolidation will be effective at 5:00 p.m. Eastern Time on August 3, 2025. The Company's common shares (the "Common Shares") are expected to begin trading on The Nasdaq Capital Market on a post-Share
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-07-31 8:01 AM EDT | Flora Growth Corp.
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), announces that the original news release captioned "PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc." published on July 30, 2025 referred, incorrectly, to the number of common shares of PharmaDrug to be issued in the second tranche of the proposed transaction and the total number of shares to be issued pursuant to both tranches. The
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 11:37 AM EDT | PharmaDrug Inc.
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is announcing that it has entered into a non-binding Letter of Intent ("LOI") on July 23rd, 2025 to acquire up to a 40% equity interest in Canurta Limited Partnership ("Canurta"), the parent entity of Canurta In
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 7:30 AM EDT | PharmaDrug Inc.
CORRECTION FROM THE SOURCE: FloraWorks Highlights New Study Showing CBN Reverses Cognitive Decline in Aging Mice
Portland, Oregon--(Newsfile Corp. - July 28, 2025) - FloraWorks, a developer of high-purity rare cannabinoid ingredients, is drawing attention to new peer-reviewed research demonstrating that Cannabinol (CBN) can reverse cognitive decline in aging mice. The study, publis
Technology, Cannabis, Health, Cannabis Manufacturer
2025-07-28 12:15 PM EDT | FloraWorks